OA17.04 The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers

Smeltzer, Matthew; Bunn, B.; Choi, Young Don; Coate, Linda; Corona-Cruz, José Francisco; Drilon, A.; Duma, Narjust; Edelman, Martin J.; Fidler, Mary J.; Gadgeel, Shirish M.; Goto, Yasushi; Herbst, Roy S.; Hesdorffer, Mary; Higgins, Kristin; Labdi, B.; Leal, Tatiana de Carvalho Andreucci Torres; Liu, S.; Mazotti, J.; Novello, Silvia; Patel, Sita Sharan

doi:10.1016/j.jtho.2021.08.093

Search citation statements

Order By: Relevance

Paper Sections

Select...

Effect Of Covid-19 On Cancer Care and Trials And Mitigation ...1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Supportive therapies to prevent cytopaenia and infection, including granulocyte colony stimulating factor and erythropoietin, were encouraged in anticipation of limited hospital bed space and blood donations. Although decentralisation of procedures and patient consultation is typically avoided in interventional clinical research, COVID-19 prompted the acceptance of remote review for cancer trials patients as telemedicine gained traction across the whole oncology community [40]. Conversion to predominantly remote consultations during the pandemic was associated with higher satisfaction than face-to-face review among cancer patients, mainly due to reduced travel time and expense with greater convenience [41].…”

Section: Effect Of Covid-19 On Cancer Care and Trials And Mitigation ...mentioning

confidence: 99%

Revitalising cancer trials post-pandemic: time for reform

et al. 2023

View full text Add to dashboard Cite

The COVID-19 pandemic posed significant risk to the health of cancer patients, compromised standard cancer care and interrupted clinical cancer trials, prompting dramatic streamlining of services. From this health crisis has emerged the opportunity to carry forward an unexpected legacy of positive reforms to clinical cancer research, where conventionally convoluted approvals processes, inefficient trial design, procedures and data gathering could benefit from the lessons in rationalisation learned during the pandemic.

show abstract

Section: Effect Of Covid-19 On Cancer Care and Trials And Mitigation ...mentioning

confidence: 99%